MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Immediate Impact of Whole-Body Vibration on Backward Walking in Individuals with Parkinson disease

    A. Boddy, K. Barta, M. Flores, K. Sawyer, L. Perry, A. Campbell (Waco, USA)

  • Immune cell changes in early Dementia with Lewy Bodies

    T. Yacoubian, H. Qin, A. Amara, N. Stover, L. Ruffrage, M. Dean, Y. Zhang, R. Kennedy, D. Geldmacher, A. Gerstenecker, D. Standaert, E. Benveniste (AURORA, USA)

  • Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

    J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)

  • Impact of Age of Symptom Onset in Essential Tremor on Cognition in Elderly Individuals

    C. Sangali, G. Pereira, A. Detogni, N. Bruscato, A. Schuh, C. Rieder (Porto Alegre, Brazil)

  • Impact of Allogeneic Mesenchymal Stem Cells in Motor and Non-Motor Symptoms of Parkinson’s Disease: A Phase 2 Randomized Trial

    M. Schiess, J. Martinez-Lemus, T. Thomas, E. Tharp, C. Onuigbo, J. Suescun, T. Ellmore, T. Le, E. Rodarte-Rascon, R. Ritter Iii, C. Green (Houston, USA)

  • Impact of Aquaporin-4 polymorphisms on Glymphatic Function and Motor Symptoms in Parkinson’s Disease

    J. Qin, M. Zhang (Hangzhou, China)

  • Impact of Cognition on Social Engagement in Community-based Older Adults with Parkinsonism

    M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

  • Impact of Constipation on Motor and Non-Motor Symptoms in G2019s Lrrk2 Parkinson’s Disease A Retrospective Study

    A. Agrebaoui, R. Zouari, A. Mousli, R. Amouri, A. Rachdi, F. Nabli, Z. Saied, S. Ben Sassi (Tunis, Tunisia)

  • Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

  • Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

    J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley